DBT, BIRAC and CEPI renew cooperation agreement for vaccine development
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Renalyx will continue operating as an independent unit within the group
From material selection to cooling tower management, every small decision affects long-term equipment reliability
New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
Subscribe To Our Newsletter & Stay Updated